Compound Partnering

Strategic Alliances

The ability to anticipate and respond to industry and client challenges is at the core of PPD’s business approach. We see strategic alliances as a logical response to the challenges of drug discovery and development in today’s changing health care environment where efficiency and speed to market are critical and multiple approaches are needed to optimize investments and build pipelines.

PPD’s compound partnering program involves a seamless connection between our development resources and the discovery efforts of our partners. In these strategic alliances, we collaborate with partners to evaluate the development potential of early stage compounds in programs that harness the strengths of our partners as well as those of PPD. The goal is to maximize our partners’ return on R&D investments while creating a balanced risk portfolio of partnered products that will enhance the rate of return on PPD’s own investments.

> Contact